PI3K/AKT interacts with the mammalian target of rapamycin (mTOR) protein, inhibits fibroblastic synoviocyte (FLS) autophagy, promotes sustained synoviocyte growth, and aggravates RA (Miryala et al., 2019). The gene discussed is AKT1; the disease is rheumatoid arthritis.